GTG.AX - Genetic Technologies Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 544.69M
Enterprise value 338.45M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1,756.58
Price/book (mrq)11.00
Enterprise value/revenue 31,511.01
Enterprise value/EBITDA 6-5.60

Trading information

Stock price history

Beta (5Y monthly) 1.99
52-week change 353.14%
S&P500 52-week change 325.71%
52-week high 30.0120
52-week low 30.0037
50-day moving average 30.0064
200-day moving average 30.0053

Share statistics

Avg vol (3-month) 310.68M
Avg vol (10-day) 311.42M
Shares outstanding 54.06B
Float 3.3B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 329 Dec 1994

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)30 Jun 2019


Profit margin 0.00%
Operating margin (ttm)-27,581.59%

Management effectiveness

Return on assets (ttm)-93.02%
Return on equity (ttm)-198.23%

Income statement

Revenue (ttm)25.44k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-92.30%
Gross profit (ttm)-250.82k
Net income avi to common (ttm)-6.43M
Diluted EPS (ttm)-0.0020
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.19M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.14
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-6.07M
Levered free cash flow (ttm)-4.43M